New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 26, 2014
13:13 EDTGALTGalectin Therapeutics volatility elevated into results from fatty liver disease
Galectin Therapeutics April call option implied volatility is at 194, May is at 143, July is at 112; compared to its 26-week average of 99 according to Track Data, suggesting large near term price movement into reporting results from the first cohort of its Phase 1 clinical trial examining GR-MD-02 in fatty liver disease.
News For GALT From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 10, 2014
09:20 EDTGALTOn The Fly: Pre-market Movers
Subscribe for More Information
08:59 EDTGALTGalectin Therapeutics GR-MD-02 Phase 1 trial meets primary endpoint
Subscribe for More Information
08:14 EDTGALTGalectin Therapeutics reports Q3 EPS (17c), consensus (27c)
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use